Page last updated: 2024-10-28

hexamethonium and Osteomyelitis

hexamethonium has been researched along with Osteomyelitis in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Osteomyelitis: INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RØNNOV-JESSEN, V1

Other Studies

1 other study available for hexamethonium and Osteomyelitis

ArticleYear
Hexamethonium treatment of arterial hypertension.
    Danish medical bulletin, 1954, Volume: 1, Issue:4

    Topics: Hexamethonium; Humans; Hypertension; Osteomyelitis

1954